Yuan Yao, MD, MS¹, Sameer A. Parikh, MBBS¹, Sara Achenbach^2*, Aaron D. Norman, MPH^3*, Kari G. Rabe, MS^2*, Nicholas J. Boddicker, PhD⁴, Janet E. Olson, PhD^3*, Rosalie Griffin, PhD⁵, Soren Basnet^6*, Dennis P. Robinson^4*, Mingma Hoel^1*, Alyssa I Clay-Gilmour, PhD⁷, Stacey Lehman^8*, Timothy G. Call, MD¹, James R. Cerhan, MD, PhD⁹, Celine M. Vachon, PhD³, Neil E. Kay, MD^1,10, Esteban Braggio, PhD¹¹, Curtis A. Hanson, MD^12*, Tait D. Shanafelt, MD^13* and Susan L. Slager, PhD^1,5

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN
³Division of Epidemiology, Mayo Clinic, Rochester, MN
⁴Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁵Division of Computational Biology, Mayo Clinic, Rochester, MN
⁶Department of Mathematics, Luther College, Decorah, IA
⁷Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC
⁸Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁹Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
¹⁰Department of Immunology, Mayo Clinic, Rochester, MN
¹¹Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ
¹²Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
¹³School of Medicine, Stanford University, Stanford, CA

Narendranath Epperla, MD, MS¹, Natalie Grover, MD², Pallawi Torka, MD³, Reem Karmali, MD⁴, Kaitlin Annunzio, DO⁵, Marcus P. Watkins, PhD^6*, Andrea Carolina Anampa-Guzmán, MD^7*, Heather Reves, MS, BS^8*, Montreh Tavakkoli, MD⁹, Beth Christian, MD¹⁰, Colin Thomas, MD¹¹, Stefan K. Barta, MD¹², Praveen Ramakrishnan Geethakumari, MD, MS⁸, Geoffrey Shouse, PhD, DO¹³, Nancy L. Bartlett, MD¹⁴ and Adam J. Olszewski, MD¹⁵

¹Division of Hematology, Department of Medicine, The Ohio State University, The James Cancer Hospital and Solove Research Institute, Columbus, OH
²University of North Carolina, Chapel Hill, NC
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁵The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
⁶Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁷Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁸Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX
⁹Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
¹⁰Division of Hematology, The Ohio State University, Columbus, OH
¹¹Department of Medicine, University of Pennsylvania, Philadelphia, PA
¹²Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
¹³City of Hope Cancer Center, Duarte, CA
¹⁴Siteman Cancer Center, Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO
¹⁵Brown University, Providence, RI

Imke E. Karsten^1*, Norbert Schmitz, MD^2*, Mathilde Fekom^3*, Laurence de Leval, MD, PhD⁴, Hervé Finel^5*, Irma Khvedelidze^6*, Won Seog Kim, MD^7*, Depei Wu, MD, PhD⁸, Montserrat Rovira, MD, PhD^9*, Fengrong WANG, MD^10*, Xiao-Jun Huang, MD, PhD¹¹, Peter Dreger¹², Johan Maertens, MD, PhD^13*, Paolo Corradini, MD¹⁴, Grzegorz Helbig^15*, Wolfgang Andreas Bethge, MD^16*, Larry Bacon, PhD, MB BCh BAO, MRCPI, FRCPath,^17*, Jan Vydra, MD^18*, Aitana Balaguer Rosello, MD, PhD^19*, Matthias Stelljes, MD^2*, Georg Lenz^20*, Alina Daniela Tanase, md, phd²¹, Anna Sureda Balari, MD, PhD²², Ali Bazarbachi, MD, PhD²³ and Bertram Glass, MD^24*

¹Department of Medicine A, University Hospital Muenster, Muenster, Germany
²Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
³European Bone Marrow Transplantation Lymphoma Working Party, Paris, France
⁴Hôpital Universitaire de Lausanne, Lausanne, Switzerland
⁵European Society for Blood and Marrow Transplantation, Paris, France
⁶Paris Study Unit, Hôpital Saint-Antoine, European Society for Blood and Marrow Transplantation, Paris, France
⁷Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁸Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
⁹Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain
¹⁰People's Hospital Institute of Hematology, Beijing, CHN
¹¹Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
¹²Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
¹³Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium
¹⁴University of Milan. Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
¹⁵Department of Hematology, Medical University of Silesia, Katowice, Poland
¹⁶Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tübingen, Germany
¹⁷National Adult Stem Cell Transplant and Adult CAR T-cell Programme, Haematology, St James's Hospital, Dublin, IRL
¹⁸Institute of Hematology and Blood Transfusion, Prague 10, CZE
¹⁹Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
²⁰University Hospital Muenster, Muenster, Germany
²¹Institutul clinic fundeni, clădirea B, director medical, Bucharest, Romania
²²Hematology Department, Institut Català d’Oncologia - Hospitalet, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Spain
²³American University of Beirut Dept. of Medicine, Beirut, Lebanon
²⁴Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany

Patrick Connor Johnson, MD¹, Richard Newcomb, MD^2*, Jeremy S. Abramson, MD¹, Ann S. LaCasce, MD³, Julia Rice^4*, Daniel Yang^5*, Bridget Coffey^6*, Sruthi K. Venkatachalam^7*, Netana H. Markovitz, M.D.^8*, Emilia Kaslow-Zieve^9*, Oreofe O. Odejide, MD¹⁰ and Areej El-Jawahri, MD⁷

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Massachusetts General Hospital, Winthrop, MA
³Dana-Farber Cancer Institute, Boston, MA
⁴The Warren Alpert Medical School of Brown University, Providence, RI
⁵Duke University School of Medicine, Durham, NC
⁶Massachusetts General Hospital, Boston
⁷Massachusetts General Hospital, Boston, MA
⁸Beth Israel Deaconess Medical Center, Boston, MA
⁹George Washington University School of Medicine, Washington, DC
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Adam Suleman, MD^1,2, Anna Santiago, MSc, PhD^3*, Tyler Pittman, MSc^3*, Gilla Shapiro, MA(Cantab), MPP/MPA, PhD, CPsych^4*, Anca Prica, MD, MSc^1*, Sita D. Bhella, MD¹, Heather Cole^5*, Katherine Zeman^5*, Gary Rodin, MD, FRCPC^6,7*, Susanna Sellmann^5*, Amit Oza, MD, MBBS, FRCP^8*, Jennifer Jones, PhD^9*, Rena M Conti, PhD^10*, Meredith Rosenthal, PhD^11* and Danielle Rodin, MD, MPH^12,13*

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³University Health Network, Toronto, ON, Canada
⁴Department of Supportive Care, University Health Network, Toronto, ON, Canada
⁵Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Department of Psychiatry, University of Toronto, Toronto, ON, Canada
⁷Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁸Division of Hematology and Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, CAN
⁹Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, ON, CAN
¹⁰Department of Markets, Public Policy, and Law, Boston University Questrom School of Business, Boston, MA
¹¹Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA
¹²Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
¹³Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada

Colleen A. Kelly, MD^1,2, Morgan A. Paul, MS^3*, Jennifer Kellett, MSW^1*, Sunyu Kang^1*, Anna Revette, PhD^4*, Rahela Aziz-Bose, MD^1,2,5,6, Leanne Duhaney, MD, MPH^7*, Puja J. Umaretiya, MD^8*, Erika Hanson, JD^9* and Kira Bona, MD, MPH^1,2,4,6

¹Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
²Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA
⁵Division of Population Sciences, Dana-Farber Cancer Institute, Jamaica Plain, MA
⁶Department of Pediatrics, Harvard Medical School, Boston, MA
⁷Department of Cardiology, Boston Children's Hospital, Boston, MA
⁸Division of Pediatric Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX
⁹Center for Health Law and Policy Innovation, Harvard Law School, Boston, MA